UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G/A

Amendment Number 1

Under the Securities Exchange Act of 1934

PHARMAGEN, INC.

(Name of issuer)

Common Stock, $0.001 value per share

(Title of class of securities)

71715W 106

(CUSIP number)

February 18, 2014

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

SEC 1745 (1-06)

Page 1 of 5 pages

CUSIP No. 71715W 106

13G/A

Page 2 of 5 Pages

1.	Name of Reporting Person I.R.S. Identification Nos. of above persons (entities only). IBC Funds LLC EIN: 45-5351131
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) o
3.	SEC Use Only
4.	Citizenship or Place of Organization Nevada
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 0
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11.	Percent of Class Represented by Amount in Row (9) 0.00%
12.	Type of Reporting Person (See Instructions) OO

CUSIP No. 71715W 106

13G/A

Page 3 of 5 Pages

Item 1	(a)	Name of Issuer:
		PHARMAGEN, INC.

	(b)	Address Of Issuer's Principal Executive Offices:
		9337 Fraser Avenue, Silver Spring, MD 20910

Item 2	(a)	Name of Person Filing:
		IBC Funds LLC

	(b)	Address of Principal Business Office, or, if none, Residence:
		5348 Vegas Drive, Las Vegas, Nevada 89108

	(c)	Citizenship:
		Nevada

	(d)	Title of Class of Securities:
		Sommon Common Stock, $0.001 value per share

	(e)	Cusip Number:
		71715W 106

Item 3	If this statement is filed pursuant to §240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

	(a)	o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

	(b)	o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

	(c)	o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

	(d)	o Investment company registered under section 8 of the Investment Company Act (15 U.S.C. 80a-8).

	(e)	o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

	(f)	o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(ii)(F).

	(g)	o A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).

	(h)	o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).

	(i)	o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

	(j)	o Group in accordance with §240.13d-1(b)(ii)(J).

CUSIP No. 71715W 106

13G/A

Page 4 of 5 Pages

Item 4

Ownership

(a) Amount beneficially owned 0

(b) Percent of class: 0.00%

(i) Sole power to vote or to direct the vote

(ii) Shared power to vote or to direct the vote

(iii) Sole power to dispose or to direct the disposition of

(iv) Shared power to dispose or to direct the disposition of

Item 5

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

Item 6

Ownership of More Than Five Percent on Behalf Of Another Person

N/A

Item 7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

N/A

Item 8

Identification and Classification of Members of The Group

N/A

Item 9

Notice of Dissolution of Group

N/A

Item 10

Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

CUSIP No. 71715W 106

13G/A

Page 5 of 5 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: July 16, 2014

	IBC Funds LLC
	Company Name

	/s/ Samuel Oshana
	Signature

	Samuel Oshana, Managing Member
	Name/Title

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties for whom copies are to be sent.

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

Pharmagen, Inc. SC 13G/A